Sowahha: A Potential Drug Target and Biomarker for Ankyrin Repeat Domain-Containing Proteins

Target Name: SOWAHA

NCBI ID: G134548

SOWAHA

Sowahha: A Potential Drug Target and Biomarker for Ankyrin Repeat Domain-Containing Proteins

Sowahha (ankyrin repeat domain-containing protein 43) is a protein that has been identified by bioinformatics analysis as having potential as a drug target or biomarker. Theankyrin repeat domain is a conserved structural motif that is found in various proteins, including enzymes, adaptors, and transporters. Sowahha is a 21-kDa protein that is expressed in various tissues and organs, including brain, heart, lungs, and gastrointestinal tract.

The Discovery of Sowahha as a Potential Drug Target

Sowahha was first identified as a potential drug target by its encoded gene, which is located on chromosome 16 and has a high degree of homology with the protein kinase A1 (KATP2). KATP2 is a well-established drug target that is involved in various cellular processes, including cell signaling, DNA replication, and cell survival. Sowahha is highly conserved with KATP2, and its amino acid sequence is similar to that of KATP2, which suggests that it may have similar functions.

Sowahha has been shown to interact with various drug molecules, including inhibitors of the A1 protein kinase. In addition, Sowahha has been shown to be involved in the regulation of cellular processes, including cell adhesion, migration, and survival. These functions make Sowahha an attractive drug target for the development of new treatments for various diseases.

The Potential of Sowahha as a Biomarker

Sowahha has also been identified as a potential biomarker for several diseases. Its expression is increased in various diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. Additionally, Sowahha has been shown to be involved in the regulation of cellular processes that are altered in these diseases, which suggests that it may be a useful biomarker for monitoring disease progression and response to therapeutic interventions.

The Expression and Localization of Sowahha

Sowahha is a cytoplasmic protein that is expressed in various tissues and organs, including brain, heart, lungs, and gastrointestinal tract. It is primarily localized to the endoplasmic reticulum (ER), where it can be detected by techniques such as Western blotting or immunofluorescence. Sowahha is also shown to be present in the cytoplasm, which suggests that it may be involved in various cellular processes that are not targeted by specific inhibitors.

Conclusion

Sowahha is a protein that has potential as a drug target or biomarker. Its high degree of homology with the protein kinase A1 and its interaction with inhibitors of the A1 protein kinase make it an attractive target for the development of new treatments for various diseases. Additionally, its expression and localization in various tissues suggest that it may be a useful biomarker for monitoring disease progression and response to therapeutic interventions. Further research is needed to fully understand the functions of Sowahha and its potential as a drug target or biomarker.

Protein Name: Sosondowah Ankyrin Repeat Domain Family Member A

The "SOWAHA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOWAHA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets